Pharma-Bio Serv, Inc.
PBSV
$0.42
-$0.16-27.16%
OTC PK
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 233.00K | 32.90K | -100.00 | -204.30K | 95.40K |
| Total Depreciation and Amortization | 13.60K | 44.20K | 59.20K | 58.30K | 60.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 9.20K | -81.70K | 152.60K | -74.90K | 46.90K |
| Change in Net Operating Assets | -621.10K | -385.50K | 68.00K | 457.40K | -504.70K |
| Cash from Operations | -365.30K | -390.10K | 279.70K | 236.50K | -301.60K |
| Capital Expenditure | -2.30K | -2.40K | -400.00 | -2.00K | -4.30K |
| Sale of Property, Plant, and Equipment | -- | 7.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.88M | 2.76M | -856.30K | 1.63M | -3.22M |
| Cash from Investing | -1.89M | 2.77M | -856.70K | 1.63M | -3.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -700.00 | -1.70K | -9.20K | -5.00K | -17.20K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -1.72M | -- | 0.00 | -- | -1.72M |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -1.72M | -1.70K | -9.20K | -5.00K | -1.74M |
| Foreign Exchange rate Adjustments | -1.40K | 9.50K | 7.70K | 4.40K | 51.50K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.97M | 2.38M | -578.50K | 1.86M | -5.21M |